胰島素注射器市場規模、佔有率及成長分析（按注射器尺寸、疾病類型、最終用途、分銷管道和地區）－2025-2032 年產業預測

2023 年全球胰島素注射器市場規模為 17 億美元，預計將從 2024 年的 17.7 億美元成長到 2032 年的 24.6 億美元，預測期間（2025-2032 年）的複合年成長率為 4.2%。

全球胰島素注射器市場正在經歷顯著成長，因為糖尿病，特別是 2 型糖尿病的盛行率正以驚人的速度成長，而久坐的生活方式、不健康的飲食、都市化和不斷上升的肥胖率都是導致這一現象的根源。國際糖尿病聯盟預測，到 2045 年，成年糖尿病患者人數將從 2021 年的 5.37 億激增至 7.83 億，這將對有效的胰島素輸送系統產生越來越大的需求。隨著諾和諾德等大型製藥公司從傳統的人類胰島素筆轉向利潤更高的 GLP-1 受體促效劑，許多患者，尤其是中低收入國家的患者，面臨著越來越少的負擔得起的選擇。因此，傳統胰島素注射器的使用再次興起，尤其是在非技術醫療環境中，這進一步刺激了市場需求。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 二次資料和一次資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態與展望

• 市場概覽
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024年）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 監管格局
• 案例研究
• 技術分析

胰島素注射器市場規模（以注射器尺寸）

• 市場概覽
• 3/10 CC注射器（0.3毫升）
• 1/2 CC注射器（0.5毫升）
• 1 CC注射器（1毫升）
• 其他

胰島素注射器市場規模（依疾病類型分類）

• 市場概覽
• 1型糖尿病
• 2型糖尿病

胰島素注射器市場規模（依最終用途）

• 市場概覽
• 醫院和診所
• 居家照護環境
• 其他

胰島素注射器市場規模（按分銷管道）

• 市場概覽
• 醫院藥房
• 零售藥局
• 網路藥局

胰島素注射器市場規模（以針頭長度）

• 市場概覽
• 短的
• 中等的
• 長的

胰島素注射器市場規模（依產品類型）

• 市場概覽
• 標準胰島素注射器
• 安全胰島素注射器

胰島素注射器市場規模

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司詳情
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Novo Nordisk A/S（Denmark）
• Eli Lilly and Company（US）
• Sanofi SA（France）
• Becton, Dickinson and Company（BD）（US）
• Terumo Corporation（Japan）
• Cardinal Health Inc.（US）
• Medtronic plc（Ireland）
• Abbott Laboratories（US）
• Nipro Corporation（Japan）
• Biocon Ltd.（India）
• Hindustan Syringes & Medical Devices Ltd.（India）
• B. Braun Melsungen AG（Germany）
• Ypsomed Holding AG（Switzerland）
• Stevanato Group SpA（Italy）
• Schott Pharma AG & Co. KGaA（Germany）
• ApiJect Systems Corporation（US）
• Teleflex Incorporated（US）
• Owen Mumford Ltd.（UK）
• Allison Medical Inc.（US）

結論和建議

Global Insulin Syringes Market size was valued at USD 1.7 billion in 2023 and is poised to grow from USD 1.77 billion in 2024 to USD 2.46 billion by 2032, growing at a CAGR of 4.2% during the forecast period (2025-2032).

The global insulin syringes market is experiencing significant growth due to the alarming rise in diabetes prevalence, particularly type 2 diabetes, fueled by sedentary lifestyles, unhealthy diets, urbanization, and increasing obesity rates. The International Diabetes Federation projects that the adult diabetes population will surge from 537 million in 2021 to 783 million by 2045, creating a heightened demand for effective insulin delivery systems. As major pharmaceutical companies like Novo Nordisk shift focus from traditional human insulin pens to higher-margin GLP-1 receptor agonists, many patients, particularly in low- and middle-income countries, are left with fewer affordable options. Consequently, there's a resurgence in the use of conventional insulin syringes, especially in healthcare settings lacking advanced technologies, further boosting market demand.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Insulin Syringes market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Insulin Syringes Market Segments Analysis

Global Insulin Syringes Market is segmented by Syringe Size, Disease Type, End-Use, Distribution Channel, Needle Length, Product Type and region. Based on Syringe Size, the market is segmented into 3/10 CC Syringe (0.3ml), 1/2 CC Syringe (0.5ml), 1 CC Syringe (1ml) and Others. Based on Disease Type, the market is segmented into Type 1 Diabetes and Type 2 Diabetes. Based on End-Use, the market is segmented into Hospitals & Clinics, Homecare Settings and Others. Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies and Online Pharmacies. Based on Needle Length, the market is segmented into Short, Medium and Long. Based on Product Type, the market is segmented into Standard Insulin Syringes and Safety Insulin Syringes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Insulin Syringes Market

The global increase in the elderly population is contributing significantly to the rise in diabetes prevalence, resulting in heightened insulin usage. As age-related diabetes cases continue to climb, the demand for insulin syringes is steadily on the rise. This trend is driving market expansion, as effective and regular insulin administration becomes increasingly essential for managing the health of diabetic patients. Consequently, the urgent need for insulin syringes as a critical tool in diabetes care is a primary factor propelling growth in the global insulin syringes market.

Restraints in the Global Insulin Syringes Market

A significant constraint within the global insulin syringes market arises from patients' reluctance to initiate or adhere to insulin therapy, primarily due to fear of needles and the discomfort associated with injections. This apprehension leads to infrequent use of syringes, which hinders overall market growth. The issue of patient compliance remains critical in effective diabetes management, and when individuals are deterred from regular insulin usage, it creates barriers to market expansion. Addressing these concerns is essential to increase acceptance and utilization of insulin syringes, ultimately improving diabetes care and enhancing market potential.

Market Trends of the Global Insulin Syringes Market

The Global Insulin Syringes market is witnessing a notable trend towards miniaturized syringes, specifically 0.5 ml variants, driven by the growing demand from pediatric patients and individuals with Type 1 diabetes. These smaller syringes enhance dosing accuracy and provide a more comfortable experience for users, addressing the critical need for improved patient compliance. As more healthcare providers and patients recognize the benefits of these compact devices, manufacturers are increasingly focusing on innovation to meet this demand. This shift is expected to significantly influence market dynamics, fostering growth and expanding the availability of user-friendly insulin delivery solutions worldwide.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technological Analysis

Global Insulin Syringes Market Size by Syringe Size & CAGR (2025-2032)

• Market Overview
• 3/10 CC Syringe (0.3ml)
• 1/2 CC Syringe (0.5ml)
• 1 CC Syringe (1ml)
• Others

Global Insulin Syringes Market Size by Disease Type & CAGR (2025-2032)

• Market Overview
• Type 1 Diabetes
• Type 2 Diabetes

Global Insulin Syringes Market Size by End-Use & CAGR (2025-2032)

• Market Overview
• Hospitals & Clinics
• Homecare Settings
• Others

Global Insulin Syringes Market Size by Distribution Channel & CAGR (2025-2032)

• Market Overview
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Global Insulin Syringes Market Size by Needle Length & CAGR (2025-2032)

• Market Overview
• Short
• Medium
• Long

Global Insulin Syringes Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Standard Insulin Syringes
• Safety Insulin Syringes

Global Insulin Syringes Market Size & CAGR (2025-2032)

• North America (Syringe Size, Disease Type, End-Use, Distribution Channel, Needle Length, Product Type)
  • US
  • Canada
• Europe (Syringe Size, Disease Type, End-Use, Distribution Channel, Needle Length, Product Type)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Syringe Size, Disease Type, End-Use, Distribution Channel, Needle Length, Product Type)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Syringe Size, Disease Type, End-Use, Distribution Channel, Needle Length, Product Type)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Syringe Size, Disease Type, End-Use, Distribution Channel, Needle Length, Product Type)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Novo Nordisk A/S (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company (U.S.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD) (U.S.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health Inc. (U.S.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (U.S.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nipro Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biocon Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hindustan Syringes & Medical Devices Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ypsomed Holding AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stevanato Group S.p.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Schott Pharma AG & Co. KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ApiJect Systems Corporation (U.S.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teleflex Incorporated (U.S.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Owen Mumford Ltd. (U.K.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Allison Medical Inc. (U.S.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations